• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


ChemPartner Opens South San Francisco, California, Research Facility

ChemPartner, a leading science-driven, technology-based, high quality preclinical research partner for healthcare companies around the world, expanded its global footprint with the establishment of a 24,000 square foot, state-of-the-art research facility in South San Francisco, California.

A service division of the ShangPharma group, ChemPartner, is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. ChemPartner's new research facility will be staffed by experienced drug research scientists from leading biotechnology companies who will collaborate closely with ChemPartner's scientists based in China.

"We are very excited to announce the opening of ChemPartner's new state-of-the-art research facility in South San Francisco, one of the global centers of innovation in life science," said ChemPartner Founder/CEO Michael Hui.

"In drug discovery, scientific excellence is the key to success," Hui continued. "By taking the CRO service business to the next level, this new facility will help enable our customers, partners, and business collaborators to interrogate the most complex of drug discovery projects."

The Company noted that the new facility is the first step in a planned build-out of ChemPartner's research presence in major innovation hubs around the world. "In addition to proximity to the top industry talent, the new facility brings ChemPartner services closer to the biopharmaceutical communities in the United States, and will enable us to develop more innovative ways to bring value to our partners," company officials said.


Exclusive Research